Your browser doesn't support javascript.
loading
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).
Feher, Michael; Hinton, William; Forbes, Anna; Munro, Neil; Joy, Mark; Wheeler, David; de Lusignan, Simon.
Afiliação
  • Feher M; Clinical Informatics and Health Outcomes Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Hinton W; Clinical Informatics and Health Outcomes Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Forbes A; Clinical Informatics and Health Outcomes Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Munro N; Clinical Informatics, University of Surrey, Guildford, United Kingdom.
  • Joy M; Clinical Informatics and Health Outcomes Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Wheeler D; Department of Renal Medicine, University College London, London, United Kingdom.
  • de Lusignan S; Clinical Informatics and Health Outcomes Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
JMIR Res Protoc ; 11(7): e34206, 2022 Jul 19.
Article em En | MEDLINE | ID: mdl-35852840

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Idioma: En Revista: JMIR Res Protoc Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Idioma: En Revista: JMIR Res Protoc Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido